|
gptkbp:instanceOf
|
gptkb:public_company
|
|
gptkbp:CEO
|
gptkb:Vas_Narasimhan
|
|
gptkbp:competitor
|
gptkb:Boehringer_Ingelheim
gptkb:Aurobindo_Pharma
gptkb:Bayer
gptkb:Pfizer
gptkb:UCB
gptkb:Takeda
gptkb:Sumitomo_Pharma
gptkb:Biogen
gptkb:Novo_Nordisk
gptkb:AstraZeneca
gptkb:Eli_Lilly
gptkb:Johnson_&_Johnson
gptkb:Merck_&_Co.
gptkb:Sanofi
gptkb:Teva_Pharmaceutical_Industries
gptkb:Sun_Pharma
gptkb:AbbVie
gptkb:Amgen
gptkb:Gilead_Sciences
gptkb:Regeneron_Pharmaceuticals
gptkb:Roche
gptkb:Astellas_Pharma
gptkb:Shionogi
gptkb:CSL_Limited
gptkb:Daiichi_Sankyo
gptkb:Bristol_Myers_Squibb
gptkb:Otsuka_Holdings
GlaxoSmithKline
|
|
gptkbp:country
|
gptkb:Switzerland
|
|
gptkbp:dividendCurrency
|
CHF
|
|
gptkbp:dividendPaying
|
annual
~3.5% (2023)
|
|
gptkbp:foundedBy
|
merger of Ciba-Geigy and Sandoz
|
|
gptkbp:foundedYear
|
1996
|
|
gptkbp:fullName
|
gptkb:Novartis_AG
|
|
gptkbp:headquartersLocation
|
gptkb:Basel,_Switzerland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NOVN
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:ISIN
|
CH0012005267
|
|
gptkbp:listedOn
|
gptkb:New_York_Stock_Exchange
gptkb:SIX_Swiss_Exchange
|
|
gptkbp:marketCap
|
over $200 billion (2024)
|
|
gptkbp:netIncome
|
$7.0 billion (2023)
|
|
gptkbp:numberOfEmployees
|
about 76,000 (2023)
|
|
gptkbp:product
|
gptkb:Signifor
gptkb:Gleevec
gptkb:Exelon
gptkb:Afinitor
gptkb:Cosentyx
gptkb:Diovan
gptkb:Entresto
gptkb:Exforge
gptkb:Exjade
gptkb:Femara
gptkb:Foradil
gptkb:Galvus
gptkb:Gilenya
gptkb:Ilaris
gptkb:Jakavi
gptkb:Kymriah
gptkb:Lamisil
gptkb:Lescol
gptkb:Lucentis
gptkb:Mekinist
gptkb:Neoral
gptkb:Promacta
gptkb:Ritalin
gptkb:Sandostatin
gptkb:Simulect
gptkb:Starlix
gptkb:Tafinlar
gptkb:Tasigna
gptkb:Tobradex
gptkb:Voltaren
gptkb:Zolgensma
gptkb:Zometa
gptkb:Inclisiran
gptkb:Adakveo
gptkb:Atectura
gptkb:Beovu
gptkb:Comtan
gptkb:Enerzair
gptkb:Kesimpta
gptkb:Leqvio
gptkb:Mayzent
gptkb:Piqray
gptkb:Pluvicto
gptkb:Resolor
gptkb:Scemblix
gptkb:Tabrecta
gptkb:Trileptal
gptkb:Votrient
|
|
gptkbp:revenue
|
$45.4 billion (2023)
|
|
gptkbp:stockExchange
|
gptkb:SIX_Swiss_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:NOVN
|
|
gptkbp:subsidiary
|
gptkb:Advanced_Accelerator_Applications
gptkb:The_Medicines_Company
gptkb:AveXis
gptkb:Chiron_Corporation
gptkb:Endocyte
gptkb:Hexal
gptkb:Sandoz_(until_2023_spin-off)
Alcon (until 2019 spin-off)
|
|
gptkbp:website
|
https://www.novartis.com/
|
|
gptkbp:主要业务
|
pharmaceuticals
biosimilars
generic drugs
|
|
gptkbp:bfsParent
|
gptkb:Novartis
|
|
gptkbp:bfsLayer
|
4
|